Ciwujianoside D1CAS# 114912-35-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 114912-35-5 | SDF | Download SDF |
| PubChem ID | 163951.0 | Appearance | Powder |
| Formula | C55H88O22 | M.Wt | 1101.29 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-6-(acetyloxymethyl)-3,4-dihydroxy-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate | ||
| SMILES | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)C)OC9C(C(C(CO9)O)O)O)C)(C)C)O)O)O)COC(=O)C)O)O)O | ||
| Standard InChIKey | SXLYHZXGNXAASM-VBSKCKADSA-N | ||
| Standard InChI | InChI=1S/C55H88O22/c1-24-34(58)37(61)41(65)47(72-24)76-44-30(23-69-25(2)56)74-45(43(67)39(44)63)71-22-29-36(60)38(62)42(66)48(73-29)77-49(68)55-18-16-50(3,4)20-27(55)26-10-11-32-52(7)14-13-33(75-46-40(64)35(59)28(57)21-70-46)51(5,6)31(52)12-15-54(32,9)53(26,8)17-19-55/h10,24,27-48,57-67H,11-23H2,1-9H3/t24-,27-,28-,29+,30+,31-,32+,33-,34-,35-,36+,37+,38-,39+,40+,41+,42+,43+,44+,45+,46-,47-,48-,52-,53+,54+,55-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Ciwujianoside D1 Dilution Calculator
Ciwujianoside D1 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 0.908 mL | 4.5401 mL | 9.0803 mL | 18.1605 mL | 22.7007 mL |
| 5 mM | 0.1816 mL | 0.908 mL | 1.8161 mL | 3.6321 mL | 4.5401 mL |
| 10 mM | 0.0908 mL | 0.454 mL | 0.908 mL | 1.8161 mL | 2.2701 mL |
| 50 mM | 0.0182 mL | 0.0908 mL | 0.1816 mL | 0.3632 mL | 0.454 mL |
| 100 mM | 0.0091 mL | 0.0454 mL | 0.0908 mL | 0.1816 mL | 0.227 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ciwujianoside D2
Catalog No.:BCX1029
CAS No.:114892-57-8
- 6-Hydroxymusizin 8-glucoside
Catalog No.:BCX1028
CAS No.:23566-96-3
- 18α,20β-Glycyrrhizic acid
Catalog No.:BCX1027
CAS No.:83896-44-0
- Gallic acid 4-O-β-D-glucopyranoside
Catalog No.:BCX1026
CAS No.:84274-52-2
- Flavanone hydrazone
Catalog No.:BCX1025
CAS No.:1692-46-2
- Notoginsenoside D
Catalog No.:BCX1024
CAS No.:193895-50-0
- Pseudoginsenoside
Catalog No.:BCX1023
CAS No.:96158-07-5
- Diphylloside A
Catalog No.:BCX1022
CAS No.:113558-11-5
- Soyasaponin Be
Catalog No.:BCX1021
CAS No.:117210-14-7
- Pseudostellarin A
Catalog No.:BCX1020
CAS No.:156430-20-5
- Furopelargone B
Catalog No.:BCX1019
CAS No.:1143-46-0
- Docosyl ferulate
Catalog No.:BCX1018
CAS No.:101927-24-6
- Ciwujianoside C4
Catalog No.:BCX1031
CAS No.:114906-75-1
- Ciwujianoside C1
Catalog No.:BCX1032
CAS No.:114906-73-9
- Agrimoniin
Catalog No.:BCX1033
CAS No.:82203-01-8
- Acetylalkannin
Catalog No.:BCX1034
CAS No.:34232-27-4
- Isoferulic Acid
Catalog No.:BCX1035
CAS No.:537-73-5
- α-Norbixin
Catalog No.:BCX1036
CAS No.:626-76-6
- 6-Iodo 5,7,3',4',5'-Pentamethoxyflavone
Catalog No.:BCX1037
CAS No.:1192850-63-7
- 3β,13-dihydroxy-ursan-28-oic acid-13-lactone
Catalog No.:BCX1038
CAS No.:29428-70-4
- Regaloside H
Catalog No.:BCX1039
CAS No.:126239-77-8
- (+)-trans-Khellactone
Catalog No.:BCX1040
CAS No.:20516-17-0
- (-)-cis-Khellactone
Catalog No.:BCX1041
CAS No.:54712-23-1
- L-1,2,3,4-Tetrahydronorharman-3-carboxylic acid
Catalog No.:BCX1042
CAS No.:42438-90-4
Molecular mechanism of Acanthopanax senticosus in the treatment of Alzheimer's disease based on network pharmacology and molecular docking.[Pubmed:36576665]
Mol Divers. 2023 Dec;27(6):2849-2865.
Alzheimer's disease is the most common neurodegenerative disease. Acanthopanax senticosus, also known as Ciwujia or Siberian ginseng in Chinese, has a wide range of antioxidant and anti-inflammatory activities. The study aims to explore the action mechanism of A. senticosus against Alzheimer's disease using network pharmacology and molecular docking. The active ingredients and targets of A. senticosus were searched through the ETCM database, and Alzheimer's disease-related targets were obtained through the OMIM and GeneCards databases. The Cytoscape 3.7.2 software was used to construct a "drug-component-target" relationship network, and the target genes of A. senticosus against Alzheimer's disease were imported into the String database to establish a protein interaction (PPI) network. The Gene Ontology and Kyoto Encyclopedia of Genes and Genomes gene enrichment analyses were performed through the Metascape database to obtain potential pathways of action of A. senticosus for the treatment of Alzheimer's disease, and the ability of these active ingredients to bind to core targets was then verified by molecular docking. 51 active ingredients were screened from A. senticosus, and 88 effective targets for Alzheimer's disease were screened. Topological and pathway-enrichment analyses revealed that A. senticosus could play a beneficial role in the treatment of Alzheimer's disease by regulating apoptosis and inflammation. Molecular docking results showed that Ciwujianoside B, Chiisanoside, and Ciwujianoside D1 had strong binding abilities to key target proteins (TNFalpha, IL1beta, and CASP3). Collectively, A. senticosus is feasible in the treatment of Alzheimer's disease.
